


<!DOCTYPE html>
<html class="writer-html5" lang="en" data-content_root="./">
<head>
  <meta charset="utf-8" /><meta name="viewport" content="width=device-width, initial-scale=1" />

  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case Study: ITH-aware Somatic Interpretation for WGS/WES &mdash; WGS/WES Pipeline 1.0.0 documentation</title>
      <link rel="stylesheet" type="text/css" href="_static/pygments.css?v=b86133f3" />
      <link rel="stylesheet" type="text/css" href="_static/css/theme.css?v=e59714d7" />
      <link rel="stylesheet" type="text/css" href="_static/graphviz.css?v=4ae1632d" />
      <link rel="stylesheet" type="text/css" href="_static/copybutton.css?v=76b2166b" />
      <link rel="stylesheet" type="text/css" href="_static/css/custom.css?v=9482ece9" />

  
    <link rel="canonical" href="https://akhileshkaushal.github.io/wgswes/casestudy.html" />
      <script src="_static/jquery.js?v=5d32c60e"></script>
      <script src="_static/_sphinx_javascript_frameworks_compat.js?v=2cd50e6c"></script>
      <script src="_static/documentation_options.js?v=4ebf8126"></script>
      <script src="_static/doctools.js?v=9bcbadda"></script>
      <script src="_static/sphinx_highlight.js?v=dc90522c"></script>
      <script src="_static/clipboard.min.js?v=a7894cd8"></script>
      <script src="_static/copybutton.js?v=f281be69"></script>
    <script src="_static/js/theme.js"></script>
    <link rel="index" title="Index" href="genindex.html" />
    <link rel="search" title="Search" href="search.html" />
    <link rel="next" title="References" href="references.html" />
    <link rel="prev" title="Stage-to-Tool Mapping With Example Commands" href="wes_cll_methods.html" />
   
  <link rel="icon" href="_static/images/favicon.ico">

</head>

<body class="wy-body-for-nav"> 
  <div class="wy-grid-for-nav">
    <nav data-toggle="wy-nav-shift" class="wy-nav-side">
      <div class="wy-side-scroll">
        <div class="wy-side-nav-search" >

          
          
          <a href="index.html" class="icon icon-home">
            WGS/WES Pipeline
          </a>
<div role="search">
  <form id="rtd-search-form" class="wy-form" action="search.html" method="get">
    <input type="text" name="q" placeholder="Search docs" aria-label="Search docs" />
    <input type="hidden" name="check_keywords" value="yes" />
    <input type="hidden" name="area" value="default" />
  </form>
</div>
        </div><div class="wy-menu wy-menu-vertical" data-spy="affix" role="navigation" aria-label="Navigation menu">
              <p class="caption" role="heading"><span class="caption-text">Sections:</span></p>
<ul class="current">
<li class="toctree-l1"><a class="reference internal" href="intro.html">WGS/WES Variant Calling Pipeline</a><ul>
<li class="toctree-l2"><a class="reference internal" href="intro.html#overview">Overview</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#use-cases">Use Cases</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#supported-data-types">Supported Data Types</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#when-to-choose-wgs-vs-wes">When to Choose WGS vs WES</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#design-principles">Design Principles</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#high-level-workflow">High-Level Workflow</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#inputs-and-outputs">Inputs and Outputs</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#quality-coverage-and-qc">Quality, Coverage, and QC</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#filtering-strategy-notes">Filtering Strategy Notes</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#reference-and-resource-recommendations">Reference and Resource Recommendations</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#reproducibility-execution">Reproducibility &amp; Execution</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#data-stewardship-compliance">Data Stewardship &amp; Compliance</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#limitations-non-goals">Limitations &amp; Non-Goals</a></li>
<li class="toctree-l2"><a class="reference internal" href="intro.html#whats-next">What’s Next</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="run_pipeline.html">Run the WGS/WES Pipeline</a><ul>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#pipeline-inputs-layout">Pipeline Inputs &amp; Layout</a></li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#step-by-step-workflow">Step-by-Step Workflow</a><ul>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#raw-read-qc">1) Raw Read QC</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#adapter-quality-trimming-optional-but-recommended-for-wes">2) Adapter/Quality Trimming (optional but recommended for WES)</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#alignment-to-reference">3) Alignment to Reference</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#duplicate-marking-bqsr">4) Duplicate Marking &amp; BQSR</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#variant-calling">5) Variant Calling</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#variant-filtering">6) Variant Filtering</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#annotation">7) Annotation</a></li>
<li class="toctree-l3"><a class="reference internal" href="run_pipeline.html#cohort-level-qc-reports">8) Cohort-Level QC &amp; Reports</a></li>
</ul>
</li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#parallelization-performance">Parallelization &amp; Performance</a></li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#wes-specific-notes">WES-Specific Notes</a></li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#expected-outputs">Expected Outputs</a></li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#troubleshooting">Troubleshooting</a></li>
<li class="toctree-l2"><a class="reference internal" href="run_pipeline.html#next-steps">Next Steps</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="advanced_analysis.html">Advanced Analysis</a><ul>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#trio-and-family-based-analysis">Trio and Family-Based Analysis</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#joint-calling-for-large-cohorts">Joint Calling for Large Cohorts</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#copy-number-variation-cnv-analysis">Copy Number Variation (CNV) Analysis</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#mitochondrial-variant-analysis">Mitochondrial Variant Analysis</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#tumor-purity-estimation-adjustment">Tumor Purity Estimation &amp; Adjustment</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#integration-and-reporting">Integration and Reporting</a></li>
<li class="toctree-l2"><a class="reference internal" href="advanced_analysis.html#next-steps">Next Steps</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="annotated_example.html">Annotated Examples &amp; Interpretation</a><ul>
<li class="toctree-l2"><a class="reference internal" href="annotated_example.html#example-tumornormal-variant-calling">Example: Tumor–Normal Variant Calling</a></li>
<li class="toctree-l2"><a class="reference internal" href="annotated_example.html#example-tumor-only-variant-calling">Example: Tumor-Only Variant Calling</a></li>
<li class="toctree-l2"><a class="reference internal" href="annotated_example.html#example-germline-variant-calling">Example: Germline Variant Calling</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="structure_and_containerisation.html">Pipeline Structure and Containerisation</a><ul>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#modular-workflow-overview">Modular Workflow Overview</a></li>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#support-for-germline-and-somatic-calling">Support for Germline and Somatic Calling</a></li>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#containerisation">Containerisation</a></li>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#scalability-and-workflow-automation">Scalability and Workflow Automation</a></li>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#example-directory-layout">Example Directory Layout</a></li>
<li class="toctree-l2"><a class="reference internal" href="structure_and_containerisation.html#best-practices-for-execution">Best Practices for Execution</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="wes_cll_methods.html">Stage-to-Tool Mapping With Example Commands</a><ul>
<li class="toctree-l2"><a class="reference internal" href="wes_cll_methods.html#example-commands-bash">Example commands (bash)</a></li>
<li class="toctree-l2"><a class="reference internal" href="wes_cll_methods.html#reproducibility-checklist">Reproducibility checklist</a></li>
</ul>
</li>
<li class="toctree-l1 current"><a class="current reference internal" href="#">Case Study: ITH-aware Somatic Interpretation for WGS/WES</a><ul>
<li class="toctree-l2"><a class="reference internal" href="#what-was-built">What Was Built</a></li>
<li class="toctree-l2"><a class="reference internal" href="#cohort-profiling-and-heterogeneity">Cohort Profiling and Heterogeneity</a></li>
<li class="toctree-l2"><a class="reference internal" href="#drug-screening-and-response-definition">Drug Screening and Response Definition</a></li>
<li class="toctree-l2"><a class="reference internal" href="#expression-signatures-predicting-response">Expression Signatures Predicting Response</a></li>
<li class="toctree-l2"><a class="reference internal" href="#mechanism-of-lenvatinib-resistance-combination-strategy">Mechanism of Lenvatinib Resistance &amp; Combination Strategy</a></li>
<li class="toctree-l2"><a class="reference internal" href="#ith-aware-somatic-interpretation-recommendations">ITH-aware Somatic Interpretation &amp; Recommendations</a></li>
<li class="toctree-l2"><a class="reference internal" href="#limitations">Limitations</a></li>
</ul>
</li>
<li class="toctree-l1"><a class="reference internal" href="references.html">References</a><ul>
<li class="toctree-l2"><a class="reference internal" href="references.html#primary-study">Primary Study</a></li>
<li class="toctree-l2"><a class="reference internal" href="references.html#supporting-literature">Supporting Literature</a></li>
<li class="toctree-l2"><a class="reference internal" href="references.html#databases-and-resources">Databases and Resources</a></li>
</ul>
</li>
</ul>

        </div>
      </div>
    </nav>

    <section data-toggle="wy-nav-shift" class="wy-nav-content-wrap"><nav class="wy-nav-top" aria-label="Mobile navigation menu" >
          <i data-toggle="wy-nav-top" class="fa fa-bars"></i>
          <a href="index.html">WGS/WES Pipeline</a>
      </nav>

      <div class="wy-nav-content">
        <div class="rst-content style-external-links">
          <div role="navigation" aria-label="Page navigation">
  <ul class="wy-breadcrumbs">
      <li><a href="index.html" class="icon icon-home" aria-label="Home"></a></li>
      <li class="breadcrumb-item active">Case Study: ITH-aware Somatic Interpretation for WGS/WES</li>
      <li class="wy-breadcrumbs-aside">
            <a href="_sources/casestudy.rst.txt" rel="nofollow"> View page source</a>
      </li>
  </ul><div class="rst-breadcrumbs-buttons" role="navigation" aria-label="Sequential page navigation">
        <a href="wes_cll_methods.html" class="btn btn-neutral float-left" title="Stage-to-Tool Mapping With Example Commands" accesskey="p"><span class="fa fa-arrow-circle-left" aria-hidden="true"></span> Previous</a>
        <a href="references.html" class="btn btn-neutral float-right" title="References" accesskey="n">Next <span class="fa fa-arrow-circle-right" aria-hidden="true"></span></a>
  </div>
  <hr/>
</div>
          <div role="main" class="document" itemscope="itemscope" itemtype="http://schema.org/Article">
           <div itemprop="articleBody">
             
  <section id="case-study-ith-aware-somatic-interpretation-for-wgs-wes">
<h1>Case Study: ITH-aware Somatic Interpretation for WGS/WES<a class="headerlink" href="#case-study-ith-aware-somatic-interpretation-for-wgs-wes" title="Link to this heading"></a></h1>
<p><strong>Focus</strong>: Sampling strategy, when to prioritize tumor-normal over tumor-only, ITH-aware filtering and reporting, RNA-based response signatures, and mechanism-informed combinations (c-Jun/JNK/β-catenin axis).</p>
<p><strong>Primary reference</strong>:
Yang <em>et al.</em>, “Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer,” <em>Cancer Cell</em> (2024), DOI: 10.1016/j.ccell.2024.03.004.</p>
<p>The study established a 399-organoid biobank from 144 PLC patients, quantified ITH, developed multi-gene response signatures, and identified c-Jun-mediated resistance to lenvatinib with a rational combination strategy.</p>
<section id="what-was-built">
<h2>What Was Built<a class="headerlink" href="#what-was-built" title="Link to this heading"></a></h2>
<p><strong>Living PLC organoid biobank</strong></p>
<ul class="simple">
<li><p><strong>Scale</strong>: 399 tumor organoids from 144 patients with primary liver cancer (PLC)</p></li>
<li><p><strong>Sampling</strong>: Multi-regional sampling from the same tumor and/or metastases</p></li>
<li><p><strong>Recapitulation</strong>: Models retained patient tumor histology, genomic (mutations, CNAs), and transcriptomic features</p></li>
<li><p><strong>Utility</strong>: Suitable for drug sensitivity screening and mechanistic work</p></li>
</ul>
<p><strong>Establishment details</strong></p>
<ul class="simple">
<li><p>Overall establishment rate: <strong>75.6%</strong></p></li>
<li><p>Success linked to:
- Viable cell proportion at acquisition
- Time from resection to processing
- Digestion method</p></li>
<li><p>Culture:
- Defined media with <strong>Noggin</strong>, <strong>Rspo1</strong>, <strong>Wnt3a</strong>, and growth factors
- Passaged every 1-3 weeks
- Recoverable after long-term cryostorage</p></li>
</ul>
</section>
<section id="cohort-profiling-and-heterogeneity">
<h2>Cohort Profiling and Heterogeneity<a class="headerlink" href="#cohort-profiling-and-heterogeneity" title="Link to this heading"></a></h2>
<p><strong>Concordance and ITH</strong></p>
<ul class="simple">
<li><p>High tissue-organoid concordance across mutations, CNAs, and expression profiles</p></li>
<li><p>Multi-region sampling revealed substantial inter- and intra-tumor heterogeneity (ITH)</p></li>
<li><p>Higher mutation/CNA ITH associated with worse overall survival</p></li>
</ul>
<p><strong>Trunk/branch structure</strong></p>
<ul class="simple">
<li><p><strong>Trunk-dominant tumors</strong>: Majority of driver events early</p></li>
<li><p><strong>Branch-dominant tumors</strong>: More late-acquired, region-specific alterations</p></li>
<li><p>Implication: Single-region analyses risk missing clinically relevant branch events</p></li>
</ul>
</section>
<section id="drug-screening-and-response-definition">
<h2>Drug Screening and Response Definition<a class="headerlink" href="#drug-screening-and-response-definition" title="Link to this heading"></a></h2>
<p><strong>Agents tested</strong></p>
<ul class="simple">
<li><p>Seven clinically relevant drugs:
- Lenvatinib
- Sorafenib
- Regorafenib
- Apatinib
- Bevacizumab
- Pemigatinib
- Ivosidenib</p></li>
<li><p>Additional agents:
- Three c-Jun inhibitors
- PKUF-01 (lenvatinib-veratramine conjugate)</p></li>
</ul>
<p><strong>Response metrics</strong></p>
<ul class="simple">
<li><p>IC50 and normalized AUC per organoid highly correlated (Spearman r &gt; 0.79)</p></li>
<li><p>Patient-level sensitivity: Worst (most resistant) region determines call</p></li>
<li><p>Sensitivity thresholds anchored to clinical ORRs:
- Lenvatinib: 24.1%
- Sorafenib: 9.2%
- Regorafenib: 11%
- Apatinib: 10.7%
- Bevacizumab: 3%</p></li>
</ul>
<p><strong>Passage stability</strong></p>
<ul class="simple">
<li><p>Most lines retained stable lenvatinib sensitivity</p></li>
<li><p>A subset gained resistance in later passages, consistent with subclone expansion</p></li>
</ul>
<p><strong>Clinical alignment</strong></p>
<ul class="simple">
<li><p>Sensitivity patterns matched patient outcomes in small sets</p></li>
<li><p>Example: Lenvatinib CR cases were sensitive in all regions; progressors had ≥1 resistant region</p></li>
</ul>
</section>
<section id="expression-signatures-predicting-response">
<h2>Expression Signatures Predicting Response<a class="headerlink" href="#expression-signatures-predicting-response" title="Link to this heading"></a></h2>
<p><strong>Lenvatinib signature</strong></p>
<ul class="simple">
<li><p>Training/validation: n=106/106 organoid models</p></li>
<li><p>254 genes correlated with sensitivity → 13-gene ML signature (e.g., JUN, HIST1H1E, WNT6A)</p></li>
<li><p>AUROC: 0.86 (train), 0.81 (validation)</p></li>
<li><p>TCGA-LIHC clustering with 254-gene set identified ~25% “sensitive” subgroup, matching clinical efficacy</p></li>
</ul>
<p><strong>Other TKIs</strong></p>
<ul class="simple">
<li><p>Sorafenib: AUROC &gt; 0.9</p></li>
<li><p>Regorafenib: AUROC &gt; 0.8</p></li>
<li><p>Apatinib: AUROC &gt; 0.7</p></li>
<li><p>Signatures aligned with patient responses where tested</p></li>
</ul>
</section>
<section id="mechanism-of-lenvatinib-resistance-combination-strategy">
<h2>Mechanism of Lenvatinib Resistance &amp; Combination Strategy<a class="headerlink" href="#mechanism-of-lenvatinib-resistance-combination-strategy" title="Link to this heading"></a></h2>
<p><strong>Upstream targets</strong></p>
<ul class="simple">
<li><p>FGFRs highly expressed in PLC organoids</p></li>
<li><p>FGFR knockdown decreased lenvatinib sensitivity</p></li>
</ul>
<p><strong>c-Jun axis</strong></p>
<ul class="simple">
<li><p>Elevated c-Jun correlates with resistance</p></li>
<li><p>Knockdown sensitized resistant models</p></li>
<li><p>Overexpression conferred resistance</p></li>
<li><p>Upstream: Wnt/β-catenin and JNK
- Knockdown → increased sensitivity
- Activation → increased resistance</p></li>
</ul>
<p><strong>PKUF-01</strong></p>
<ul class="simple">
<li><p>Designed to co-target FGFR and c-Jun</p></li>
<li><p>Reduced IC50s vs lenvatinib in 20% of resistant organoids</p></li>
<li><p>Xenograft studies confirmed efficacy</p></li>
<li><p>Limitation: Oral absorption in vivo was suboptimal</p></li>
</ul>
</section>
<section id="ith-aware-somatic-interpretation-recommendations">
<h2>ITH-aware Somatic Interpretation &amp; Recommendations<a class="headerlink" href="#ith-aware-somatic-interpretation-recommendations" title="Link to this heading"></a></h2>
<p><strong>Why ITH matters</strong></p>
<ul class="simple">
<li><p>Multi-region sampling revealed extensive ITH; ignoring it risks overestimating drug efficacy</p></li>
<li><p>Considering only the most resistant region dropped predicted benefit from 72.9% (organoid-level) to 37.1% (patient-level)</p></li>
</ul>
<p><strong>Sampling strategy</strong></p>
<ul class="simple">
<li><p>Use multi-region tumor sampling whenever possible</p></li>
<li><p>Prioritize tumor-normal over tumor-only for confident somatic calls and contamination estimation</p></li>
<li><p>Include spatially distinct sites (and metastases, if available)</p></li>
<li><p>Map and annotate region-private drivers</p></li>
</ul>
<p><strong>ITH-aware filtering</strong></p>
<ul class="simple">
<li><p>Consolidate calls across regions; categorize as trunk, branch, or region-private mutations</p></li>
<li><p>Apply “worst-region” principle for therapy sensitivity calls</p></li>
</ul>
<p><strong>RNA-based response signatures</strong></p>
<ul class="simple">
<li><p>Incorporate pre-treatment RNA-seq from the same regions used for DNA sequencing</p></li>
<li><p>Compute per-region signature scores for TKIs; default to most resistant score when discordant</p></li>
<li><p>Use as enrichment tools, not definitive diagnostics</p></li>
</ul>
<p><strong>Mechanism-aware reporting</strong></p>
<ul class="simple">
<li><p>Identify resistance-linked pathways such as c-Jun/JNK/β-catenin</p></li>
<li><p>Flag candidates for mechanism-informed combinations (e.g., lenvatinib + c-Jun or JNK inhibitors, PKUF-01)</p></li>
<li><p>Include relevant clinical trial IDs when possible</p></li>
</ul>
<p><strong>Implementation tips</strong></p>
<ul class="simple">
<li><p>Use matched normals where possible for cleaner somatic calls</p></li>
<li><p>Maintain PoN and germline resource VCFs for tumor-only contexts</p></li>
<li><p>Log all tool versions and container IDs for reproducibility</p></li>
</ul>
</section>
<section id="limitations">
<h2>Limitations<a class="headerlink" href="#limitations" title="Link to this heading"></a></h2>
<ul class="simple">
<li><p>Small clinical validation set — signatures are research-grade</p></li>
<li><p>Passage-dependent drift in a minority of lines</p></li>
<li><p>PKUF-01 oral formulation limits in vivo</p></li>
</ul>
</section>
</section>


           </div>
          </div>
          <footer><div class="rst-footer-buttons" role="navigation" aria-label="Footer">
        <a href="wes_cll_methods.html" class="btn btn-neutral float-left" title="Stage-to-Tool Mapping With Example Commands" accesskey="p" rel="prev"><span class="fa fa-arrow-circle-left" aria-hidden="true"></span> Previous</a>
        <a href="references.html" class="btn btn-neutral float-right" title="References" accesskey="n" rel="next">Next <span class="fa fa-arrow-circle-right" aria-hidden="true"></span></a>
    </div>

  <hr/>

  <div role="contentinfo">
    <p>&#169; Copyright 2025, Akhilesh Kaushal.</p>
  </div>

   

</footer>
        </div>
      </div>
    </section>
  </div>
  <script>
      jQuery(function () {
          SphinxRtdTheme.Navigation.enable(true);
      });
  </script> 

</body>
</html>